Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ganciclovir.

× No keyword cloud information.

88 in total

1. Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency.

Authors: D G Wolf; I Yaniv; S Ashkenazi; A Honigman
Journal: Antimicrob Agents Chemother Date: 2001-02 Impact factor: 5.191

2. Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.

Authors: E A Gustafson; R F Schinazi; J D Fingeroth
Journal: J Virol Date: 2000-01 Impact factor: 5.103

3. Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.

Authors: D G Wolf; C T Courcelle; M N Prichard; E S Mocarski
Journal: Proc Natl Acad Sci U S A Date: 2001-02-13 Impact factor: 11.205

4. Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.

Authors: Paula M Krosky; Katherine Z Borysko; M Reza Nassiri; Rodrigo V Devivar; Roger G Ptak; Michelle G Davis; Karen K Biron; Leroy B Townsend; John C Drach
Journal: Antimicrob Agents Chemother Date: 2002-02 Impact factor: 5.191

Review 5. [Specific infections in organ transplantation].

Authors: M Cornberg; B Schlevogt; J Rademacher; A Schwarz; M Sandherr; G Maschmeyer
Journal: Internist (Berl) Date: 2016-01 Impact factor: 0.743

6. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Authors: Karen K Biron; Robert J Harvey; Stanley C Chamberlain; Steven S Good; Albert A Smith; Michelle G Davis; Christine L Talarico; Wayne H Miller; Robert Ferris; Ronna E Dornsife; Sylvia C Stanat; John C Drach; Leroy B Townsend; George W Koszalka
Journal: Antimicrob Agents Chemother Date: 2002-08 Impact factor: 5.191

7. Characterization of human T lymphocytes engineered to express interleukin-15 and herpes simplex virus-thymidine kinase.

Authors: Cary Hsu; John D Abad; Richard A Morgan
Journal: J Surg Res Date: 2013-04-03 Impact factor: 2.192

8. Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.

Authors: David L Evers; Gloria Komazin; Roger G Ptak; Dongjin Shin; Brian T Emmer; Leroy B Townsend; John C Drach
Journal: Antimicrob Agents Chemother Date: 2004-10 Impact factor: 5.191

9. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments.

Authors: T Cihlar; M D Fuller; J M Cherrington
Journal: J Virol Date: 1998-07 Impact factor: 5.103

10. Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.

Authors: Gloria Komazin; Roger G Ptak; Brian T Emmer; Leroy B Townsend; John C Drach
Journal: J Virol Date: 2003-11 Impact factor: 5.103